• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

联合化疗治疗晚期霍奇金病的复发模式。

Patterns of relapse in advanced Hodgkin's disease treated with combination chemotherapy.

作者信息

Young R C, Canellos G P, Chabner B A, Hubbard S M, DeVita V T

出版信息

Cancer. 1978 Aug;42(2 Suppl):1001-7. doi: 10.1002/1097-0142(197808)42:2+<1001::aid-cncr2820420723>3.0.co;2-z.

DOI:10.1002/1097-0142(197808)42:2+<1001::aid-cncr2820420723>3.0.co;2-z
PMID:688174
Abstract

One hundred sixty-one patients with advanced Hodgkin's disease achieved complete remission after combination chemotherapy. Of these, 52 (32%) have subsequently relapsed and the patterns of relapse have been studied. The probability of relapse increases with increasing stage and particularly with the presence of systemic symptoms. Patients with Nodular Sclerosis histology are more likely to relapse than those with other histologies. Patients relapse primarily (92%) in sites of previous disease and particularly in nodal sites (75%). Nodal sites most frequently involved at relapse are the central nodal areas and the left supraclavicular area. When patients relapse in new sites they tend to be either adjacent to sites of previous disease which relapse or to be contiguous with previously involved sites of disease. In the small number of patients who received prophylactic radiation therapy to sites of nodal disease after complete remission, the pattern of relapse was not significantly altered.

摘要

161例晚期霍奇金病患者在联合化疗后实现完全缓解。其中,52例(32%)随后复发,且对复发模式进行了研究。复发概率随分期增加而升高,特别是存在全身症状时。结节硬化组织学类型的患者比其他组织学类型的患者更易复发。患者主要(92%)在既往病变部位复发,尤其是淋巴结部位(75%)。复发时最常累及的淋巴结部位是中央淋巴结区和左锁骨上区。当患者在新部位复发时,往往与既往复发的病变部位相邻或与既往受累的病变部位相连。在少数完全缓解后接受了淋巴结疾病部位预防性放射治疗的患者中,复发模式未发生显著改变。

相似文献

1
Patterns of relapse in advanced Hodgkin's disease treated with combination chemotherapy.联合化疗治疗晚期霍奇金病的复发模式。
Cancer. 1978 Aug;42(2 Suppl):1001-7. doi: 10.1002/1097-0142(197808)42:2+<1001::aid-cncr2820420723>3.0.co;2-z.
2
Combination chemotherapy in advanced and recurrent Hodgkin's disease.晚期及复发性霍奇金病的联合化疗
Natl Cancer Inst Monogr. 1973 May;36:395-402.
3
The therapeutic implications of splenic involvement in stage IIIA Hodgkin's disease.
Cancer. 1977 May;39(5):2158-65. doi: 10.1002/1097-0142(197705)39:5<2158::aid-cncr2820390532>3.0.co;2-4.
4
Long term remissions with combined modality therapy for advanced Hodgkin's disease.晚期霍奇金病综合治疗的长期缓解
Cancer. 1976 Jun;37(6):2826-33. doi: 10.1002/1097-0142(197606)37:6<2826::aid-cncr2820370638>3.0.co;2-f.
5
[Peculiarities of the recurrence of lymphogranulomatosis in children following combined chemotherapy].[儿童淋巴肉芽肿病联合化疗后复发的特点]
Vopr Onkol. 1983;29(8):12-5.
6
[Recurrence in Hodgkin's disease: incidence, therapy and prognosis. (Experience with 134 patients)].[霍奇金淋巴瘤的复发:发病率、治疗与预后。(134例患者的经验)]
Wien Klin Wochenschr. 1983 May 13;95(10):326-32.
7
Combinaed chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for patients with advanced Hodgkin's disease. An alternative program to MOPP.对于晚期霍奇金病患者,采用环磷酰胺、长春花碱、丙卡巴肼和泼尼松联合化疗(CVPP)。这是一种替代MOPP方案的治疗计划。
Cancer. 1976 Jul;38(1):42-8. doi: 10.1002/1097-0142(197607)38:1<42::aid-cncr2820380108>3.0.co;2-u.
8
[Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].[150例早期霍奇金淋巴瘤的综合治疗]
Zhonghua Zhong Liu Za Zhi. 2008 Aug;30(8):630-4.
9
Non-Hodgkin's lymphoma: patterns of relapse from complete remission after combination chemotherapy.非霍奇金淋巴瘤:联合化疗后完全缓解后的复发模式。
Cancer. 1975 Feb;35(2):354-7. doi: 10.1002/1097-0142(197502)35:2<354::aid-cncr2820350209>3.0.co;2-2.
10
Combination chemotherapy of Hodgkin's disease in children.儿童霍奇金病的联合化疗
Cancer. 1976 Oct;38(4):1494-7. doi: 10.1002/1097-0142(197610)38:4<1494::aid-cncr2820380408>3.0.co;2-e.

引用本文的文献

1
Outcomes and relapse patterns following chemotherapy in advanced Hodgkin lymphoma in the positron emission tomography era.正电子发射断层扫描时代晚期霍奇金淋巴瘤化疗后的结局及复发模式
Blood Lymphat Cancer. 2018 Apr 18;8:13-20. doi: 10.2147/BLCTT.S160404. eCollection 2018.
2
The case for combined-modality therapy for limited-stage Hodgkin's disease.局限性 Hodgkin 病采用联合治疗模式的理由。
Oncologist. 2012;17(8):1006-10. doi: 10.1634/theoncologist.2012-0148. Epub 2012 Jul 17.
3
Changing role and decreasing size: current trends in radiotherapy for Hodgkin's disease.
Curr Oncol Rep. 2002 Sep;4(5):415-23. doi: 10.1007/s11912-002-0036-9.
4
Prognostic factors in COPP-treated patients with Hodgkin's disease.接受COPP治疗的霍奇金病患者的预后因素。
Blut. 1982 Jun;44(6):339-48. doi: 10.1007/BF00319917.
5
Current management of Hodgkin's disease.霍奇金淋巴瘤的当前治疗方法。
Drugs. 1985 Oct;30(4):355-67. doi: 10.2165/00003495-198530040-00004.
6
Prognostic value of response after three MOPP cycles in Hodgkin's disease--stage III and IV.
Blut. 1987 Mar;54(3):171-7. doi: 10.1007/BF00320373.
7
[Hodgkin's disease. Results in diagnosis and treatment (author's transl)].[霍奇金病。诊断与治疗结果(作者译)]
Klin Wochenschr. 1979 Apr 17;57(8):371-81. doi: 10.1007/BF01480475.